RxDoctor Payments Data

Heather McGovern, MD

Family Medicine · Sparta, MINPI 1902246085

Payments from drug & device makers

$310in general payments, 2019–2025

Across 18 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$151
  • Sanofi-aventis U.S. LLC$48
  • Medtronic$28
  • Lilly USA, LLC$23
  • GSK$23
  • AstraZeneca$13
  • plus $23 from 2 others

What the payments were for

  • Food & beverage$310100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$310 in reported general payments places this provider in the 50th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$26,890
Medicare patients
95
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide45$59,788
EliquisApixaban57$59,161
JardianceEmpagliflozin51$58,784
TrulicityDulaglutide37$57,693
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$35,458
Soliqua 100-33Insulin Glargine/Lixisenatide34$32,485
OzempicSemaglutide12$20,083
JanuviaSitagliptin Phosphate13$19,942
Spiriva RespimatTiotropium Bromide12$11,887
MyrbetriqMirabegron16$9,873
Fluticasone-SalmeterolFluticasone Propion/Salmeterol41$8,438
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$8,354
Incruse ElliptaUmeclidinium Bromide16$7,508
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$7,445
Rosuvastatin Calcium285$5,468

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$23$117,48182 claims
PfizerEliquis$12$59,16157 claims
GSKTrelegy Ellipta, Incruse Ellipta$23$42,96659 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$48$32,48534 claims
Novo NordiskOzempic$151$20,08312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Sparta

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →